{
  "denotations": [
    {
      "id": "T1",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 24,
        "end": 29
      }
    },
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 94,
        "end": 106
      }
    },
    {
      "id": "T5",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 192,
        "end": 197
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "26086347_5",
  "text": "RESULTS : Patients with ABCG2 421 CA or AA genotypes had 2.9 times greater odds of developing atorvastatin dose-dependent ADRs ( OR : 2.91 ; 95 % CI : 1.22-6 .95 ; p = 0.016 ) than those with ABCG2 421CC genotype ."
}
